Filters
reset allOther countries
Results: 1 to 14 of 14
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
PSEN2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 78 | 76 |
|
Amyotrophic Lateral Sclerosis (ALS) / Dementia Panel Centogene AG - the Rare Disease Company Germany | 64 | 66 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 345 | 159 |
|
Invitae United States | 72 | 33 |
|
Dilatative Cardiomyopathy Panel (DCM Panel) Labor Dr. Wisplinghoff Germany | 43 | 43 |
|
Fulgent Genetics United States | 2 | 1 |
|
Early Onset Familial Alzheimer Disease (EOFAD) NGS Panel Fulgent Genetics United States | 9 | 3 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Sudden Death Syndrome NGS Panel Fulgent Genetics United States | 168 | 68 |
|
Parkinson-Alzheimer-Dementia NGS Panel Fulgent Genetics United States | 77 | 39 |
|
Comprehensive Cardiovascular NGS Panel Fulgent Genetics United States | 671 | 250 |
|
Results: 1 to 14 of 14
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.